Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dopamine transporter binding in chronic manganese intoxication.

Chin-Chang Huang1, Yi-Hsin Weng, Chin-Song Lu

  • 1Dept. of Neurology, Chang Gung Memorial Hospital, 199, Tung-Hwa North Road, Taipei, Taiwan. cch0537@adm.cgmh.org.tw

Journal of Neurology
|December 4, 2003
PubMed
Summary

Chronic manganese exposure causes parkinsonism, but not primarily by damaging dopamine transporters. (99m)Tc-TRODAT-1 SPECT imaging helps distinguish manganism from Parkinson's disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A clinically feasible framework to estimate tau pathology and clinical-biological discordance in the Alzheimer's disease spectrum.

Alzheimer's research & therapy·2026
Same author

Taiwan Clinical Practice Guidelines for Myasthenia Gravis.

Acta neurologica Taiwanica·2026
Same author

ADAS-Cog11 performance as a surrogate of tau PET burden in an Asian Alzheimer's disease cohort.

Journal of Alzheimer's disease : JAD·2026
Same author

Plasma pTau217 and Neurofilament Light Chain as Differentiative Markers for Progressive Supranuclear Palsy From Parkinson Disease.

Neurology·2025
Same author

Neuronal-specific antibody in patients with multiple system atrophy and progressive supranuclear palsy.

Journal of the Formosan Medical Association = Taiwan yi zhi·2025
Same author

Visual interpretation of [<sup>18</sup>F]Florzolotau Tau-PET imaging for differentiating alzheimer's disease and progressive supranuclear palsy.

European journal of nuclear medicine and molecular imaging·2025

Area of Science:

  • Neuroscience
  • Toxicology
  • Radiology

Background:

  • Chronic manganese exposure can lead to parkinsonism with clinical features distinct from idiopathic Parkinson's disease (PD).
  • The precise mechanisms underlying manganese-induced parkinsonism are not fully understood.
  • Dopamine transporter (DAT) imaging using (99m)Tc-TRODAT-1 reflects presynaptic dopaminergic terminal function.

Purpose of the Study:

  • To evaluate dopamine transporter (DAT) function using (99m)Tc-TRODAT-1 SPECT.
  • To investigate the integrity of presynaptic dopaminergic terminals in patients with manganese-induced parkinsonism.
  • To differentiate chronic manganism from Parkinson's disease using DAT imaging.

Main Methods:

  • Brain (99m)Tc-TRODAT-1 SPECT imaging was performed on 4 patients with chronic manganese intoxication.

Related Experiment Videos

  • Clinical data and Unified Parkinson's Disease Rating Scale scores were collected for manganism patients.
  • Control groups included 12 patients with PD and 12 healthy volunteers.

    • Main Results:

    • Manganism patients exhibited a bradykinetic-rigid syndrome.
    • (99m)Tc-TRODAT-1 uptake values in the corpus striatum of manganism patients were significantly higher than in PD patients but slightly lower than in healthy controls.
    • A mild decrease in (99m)Tc-TRODAT-1 uptake was observed in the putamen of manganism patients compared to controls, suggesting presynaptic dopaminergic terminals are not the primary target.

    Conclusions:

    • Presynaptic dopaminergic terminals are not the main target of chronic manganese intoxication.
    • (99m)Tc-TRODAT-1 SPECT is a valuable tool for differentiating chronic manganism from Parkinson's disease.
    • This imaging technique offers a convenient and cost-effective method for differential diagnosis.